Drug promotional practices in Mumbai: a qualitative study
Nobhojit Roy1, Neha Madhiwalla, Sanjay A Pai
1Forum for Medical Ethics, Mumbai, India. nobsroy@yahoo.com
Indian Journal of Medical Ethics
|July 17, 2008
Summary
Drug companies, chemists, and doctors form an unethical alliance, using misleading information and incentives to boost drug sales, often at the public
Area of Science:
- Pharmaceutical Marketing
- Public Health Ethics
- Healthcare Economics
Background:
- Promotional practices significantly influence drug prescribing and usage patterns.
- Understanding these practices is crucial for safeguarding public health and ensuring ethical pharmaceutical markets.
- Previous research has highlighted various aspects of drug promotion, but a comprehensive view of the interrelationships between stakeholders is often lacking.
Purpose of the Study:
- To explore the range of promotional practices influencing drug usage in Mumbai.
- To identify the key stakeholders involved in these practices and their interrelationships.
- To understand the ethical implications of these promotional strategies on consumers and public health.
Main Methods:
- A qualitative study design was employed.
- Data collection involved open-ended interviews with 15 drug company executives, 25 chemists, and 25 doctors.
- Focus group discussions were conducted with 36 medical representatives.
Main Results:
- An "unholy alliance" was identified among manufacturers, chemists, and doctors, prioritizing profit over public health.
- Misleading information, incentives (e.g., conference sponsorships), and unethical trade practices are common methods to increase drug prescription and sales.
- Chemists play a significant role by directly providing drug information to patients, while medical representatives were found to be the least powerful group.
Conclusions:
- The findings reveal a system where profit motives override ethical considerations in the pharmaceutical market.
- Unethical promotional practices, including the manipulation of information and incentives, are pervasive.
- Regulatory oversight and ethical guidelines need strengthening to protect consumers and public health from such practices.
More Related Videos
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
08:27Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
Published on: September 27, 2019
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...